Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.
A frozen custard stand that has become an iconic part of summers in Rochester celebrates its 100th anniversary in 2026. The ...
Over the years, John Abbott has been a fan favorite who continued to appear on The Young and the Restless even after his ...
Abbott's broad healthcare reach and Intuitive's robotic surgery focus present distinct financial strengths and risks for ...
Abbott and Danaher both reported Q1 2026 results, but the businesses underneath those numbers point in opposite directions, ...
Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.
Abbott Laboratories is one of the world's leading medical device makers. It routinely develops and markets newer products, and its portfolio boasts dozens of patented devices that generate consistent ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The escalating battle between Texas Governor Greg Abbott and the Biden ...
Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...
May 31 (Reuters) - Healthcare company Abbott Laboratories (ABT.N), opens new tab on Tuesday sued one of its former scientists, accusing him in U.S. court of "secretly downloading" sensitive corporate ...